Platelet inhibition after switching from atorvastatin to rosuvastatin or pravastatin in patients with increased platelet reactivity during atorvastatin + clopidogrel treatment

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Jul 2012

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Pravastatin (Primary) ; Rosuvastatin (Primary) ; Aspirin; Clopidogrel
Indications Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis
Focus Pharmacodynamics; Pharmacogenomic
Acronyms ACCEL-STATIN

01 Dec 2011 New trial record
11 Nov 2011 Results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com